Autolus Therapeutics AUTL
NASDAQ AUTL
$1.21 -0.02 (-2.02%)
As of: Nov 12, 2026 · 10:36 AM EST

Autolus Therapeutics (AUTL) Return on Invested Capital [ROIC] (2019)

Updated

Autolus Therapeutics' Return on Invested Capital [ROIC] was -36.06% in FY2019.

Analysis

Autolus Therapeutics (AUTL) Return on Invested Capital [ROIC] (2019) Analysis & Trends

  • Per Business Quant data, Return on Invested Capital [ROIC] in earlier years was -9.09% in FY2018.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROIC (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 30.89%
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 17.57%
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 24.28%
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 2.52%
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 23.11%
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 15.60%
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn -6.11%
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 12.34%
10 Autolus Therapeutics 468.91 Mn -511.27 Mn 23.31 Mn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2019 -37.04%
API Access

Autolus Therapeutics Return on Invested Capital [ROIC] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-invested-capital-%5Broic%5D&ticker=AUTL&period=max&api_key=YOUR_API_KEY